What's Happening?
The San Francisco Giants finished the 2026 MLB season with a 65-97 record, placing fourth in the National League West. A significant factor in their struggles was the bullpen's performance, which ranked 19th in the majors with a 4.14 ERA and 24th with a 1.42
WHIP. The relief staff also struggled with control and strikeouts, issuing walks at a 4.20/9 ratio (23rd in MLB) and recording strikeouts at a 7.55/9 ratio (last in MLB). Despite these issues, the bullpen was effective at limiting home runs, ranking seventh in the majors by allowing only 0.95 homers per nine innings. This home run suppression is partly attributed to Oracle Park's pitcher-friendly conditions, which rank 26th overall and 28th specifically for home runs according to Statcast Park Factors. As the offseason approaches, the Giants are expected to prioritize strengthening their bullpen, with veteran left-hander Steven Okert identified as a potential target for a reunion.
Why It's Important?
The San Francisco Giants' poor 2026 season highlights critical deficiencies within their pitching staff, particularly the bullpen. The team's inability to secure leads and consistently perform in late-game situations directly contributed to their losing record, impacting fan engagement and potential revenue. A significant overhaul of the bullpen is crucial for the team to become competitive in the challenging National League West. Investing in established relief pitchers like Steven Okert, who had a career-best season with a 2.13 ERA and 0.87 WHIP in 2026, could address the team's weaknesses in strikeouts and walk rates. The decision to pursue specific free agents will also reflect the team's strategic direction—whether they aim for immediate contention or a more gradual rebuild. The financial implications of signing veteran players versus developing internal talent will also play a role in shaping the team's future competitiveness and financial health.
What's Next?
The San Francisco Giants are expected to actively seek bullpen upgrades during the upcoming offseason. Their focus will likely be on acquiring established arms to improve their strikeout rates and control, areas where they ranked among the worst in MLB in 2026. Veteran left-hander Steven Okert, who previously played for the Giants from 2016 to 2018, is considered a strong candidate for acquisition. Okert's impressive 2026 season with the Astros, where he posted a 2.13 ERA and 0.87 WHIP, makes him an attractive option, especially given his projected manageable one-year deal worth around $6.6 million. The team will also need to assess other free-agent options and potential trade opportunities to address their pitching needs comprehensively. The success of their offseason moves will largely determine their competitiveness in the 2027 season and beyond.
Beyond the Headlines
The San Francisco Giants' struggles in 2026 extend beyond just bullpen statistics, reflecting broader challenges in team construction and player development. The reliance on Oracle Park's pitcher-friendly environment to mask some pitching deficiencies suggests a need for more fundamentally strong pitching talent rather than just those who might benefit from specific park factors. The potential reunion with Steven Okert highlights a common strategy in baseball: bringing back former players who have found success elsewhere, hoping they can replicate that performance in a familiar environment. This approach can offer a sense of continuity and potentially lower the risk associated with new acquisitions. However, it also raises questions about the team's ability to scout and develop new talent effectively. The team's offseason strategy will be a critical indicator of its long-term vision, balancing immediate competitive needs with sustainable growth and development.
